SOLICITATION NOTICE
H -- Using Transgenic Mouse to Generate Human Antibodies
- Notice Date
- 5/17/2022 6:30:11 AM
- Notice Type
- Solicitation
- NAICS
- 541714
— Research and Development in Biotechnology (except Nanobiotechnology)
- Contracting Office
- CDC OFFICE OF ACQUISITION SERVICES ATLANTA GA 30333 USA
- ZIP Code
- 30333
- Solicitation Number
- 75D301-22-Q-74781
- Response Due
- 5/31/2022 2:00:00 PM
- Archive Date
- 06/15/2022
- Point of Contact
- Joseph Gugumuck, Phone: 7037127645
- E-Mail Address
-
qna4@cdc.gov
(qna4@cdc.gov)
- Description
- CDC seeks to test a transgenic mouse model that is engineered with human immunoglobulin gene segments to produce humanized antibodies, with the goal of determining if the antibodies generated from that mouse model can better recapitulate the antibody repertoire from humans. ��� Overall objective is to provide the Influenza Division with transgenic mice that express human antibody repertoire, which would be useful for assessing the efficacy of CVVs and developing antibodies.
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/b69837c6d9fa4e25aead542e58e922cf/view)
- Place of Performance
- Address: Atlanta, GA 30329, USA
- Zip Code: 30329
- Country: USA
- Zip Code: 30329
- Record
- SN06329166-F 20220519/220517230101 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |